Videos

Dace L. Trence, MD, FACE received her MD degree from the University of Minnesota Medical School.  She completed an internal medicine residency through Northwestern Hospital in Minneapolis and, subsequently, returned to the University of Minnesota for Endocrine Fellowship.  Dr. Trence started practice with Group Health, Inc, in Minnesota, becoming Chief of Endocrinology, initiating several programs, including a Lipids Clinic, Diabetes Foot Care Clinic, and a Diabetes and Pregnancy Clinic.  After moving to Seattle to practice at Group Health of Puget Sound, becoming Chief of Endocrinology, then Chief of Medical Subspecialties, she then joined the faculty at the University of Washington. Currently she is a Professor in the Department of Medicine,  Director of the Diabetes Care Center and Director of the Endocrine Fellowship Program at the University of Washington.

In this Exclusive Interview transcript, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the benefits of CGMs and what changes they have brought to blood glucose measurement and the treatment of diabetes.

In this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the benefits of CGMs and other therapies in the treatment of diabetes.

In part 1 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about her work and the positive effects of CGMs on the management of diabetes.

In part 2 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the current usefulness of the A1C test.

In part 3 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the usefulness of CGMs for people who are not on insulin therapy.

In part 4 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the latest treatments and possible treatments coming down the pike in diabetes care.

In part 5, the conclusion of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about diabetes and cardiovascular combo therapy, and how new medications and precision medicine are changing diabetes care.

Stanley Schwartz, MD, FACP, FACE is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa.  Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.

Transcript of our Exclusive Interview: Stanley Schwartz talks with Diabetes in Control Publisher Steve Free during the AACE 2018 convention in Boston about the changing classifications of diabetes, why we need to move beyond thinking in terms of type 1 and type 2, and the need for precision medicine in treating patients with all types of diabetes.